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The mTORC1 node plays a major role in autophagy modulation. We report a role of the
ubiquitous Gαq subunit, a known transducer of plasma membrane G protein-coupled
receptors signaling, as a core modulator of mTORC1 and autophagy. Cells lacking Gαq/11
display higher basal autophagy, enhanced autophagy induction upon different types of
nutrient stress along with a decreased mTORC1 activation status. They are also unable
to reactivate mTORC1 and thus inactivate ongoing autophagy upon nutrient recovery.
Conversely, stimulation of Gαq/11 promotes sustained mTORC1 pathway activation and
reversion of autophagy promoted by serum or amino acids removal. Gαq is present in
autophagic compartments and lysosomes and is part of the mTORC1 multi-molecular com-
plex, contributing to its assembly and activation via its nutrient status-sensitive interaction
with p62, which displays features of a Gαq effector. Gαq emerges as a central regulator of the
autophagy machinery required to maintain cellular homeostasis upon nutrient fluctuations.
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The highly conserved macroautophagy process, hereinafterreferred to as autophagy, constitutes a core homeostaticprocess that contributes to proper cell function through the
degradation and recycling of cytoplasmic constituents. Autop-
hagy allows for lysosomal degradation of cellular components
either in basal conditions or in response to perturbations of the
intracellular or extracellular microenvironment1,2. Consistent
with such a central role, alterations in autophagy-related path-
ways and machinery have been related to relevant pathological
conditions, such as metabolic, degenerative, inflammatory, car-
diovascular, or cancer diseases3–5.
The molecular machinery involved in autophagy has been
extensively characterized. In mammalian cells, membranes of
varied origins (including endoplasmic reticulum, mitochondria,
plasma membrane, or endosomes) form phagophores, which then
expand and fuse to form autophagosomes, the transient double-
membrane organelles that mediate cargo sequestration and
delivery to lysosomes6,7. Lipidated LC3-I (referred to as LC3-II) is
generated onto forming autophagosomes and allows for substrate
loading upon binding to several receptors of autophagy, including
p62/Sequestosome1 (p62/SQSTM1, hereafter p62). During
autophagy, both LC3-II and the cargo receptors are degraded8.
Autophagosomes fuse with lysosomes forming autolysosomes,
where lysosomal hydrolytic enzymes degrade the engulfed sub-
strates in order to release the resulting molecules to the cytosol.
Finally, autolysosomes contribute to the regeneration of the
lysosomal pool9.
The signaling networks that underlie autophagy modulation in
response to nutrient fluctuations, thus allowing cells to coordinate
their metabolic activity and growth, remain to be fully under-
stood. Changes in intracellular nutrient and energy status are
mainly conveyed to the autophagic machinery via modulation of
the mammalian target of rapamycin complex 1 (mTORC1) and
AMP-activated protein kinase (AMPK) signaling cascades. In
response to prolonged stress, autophagy is also regulated at the
transcriptional level via transcription factors as TFEB or FoxO310.
The mTORC1 hub integrates signals from many stimuli,
including amino acids, energy levels, glucose, oxygen, growth
factors, and stress to coordinate the induction of anabolic
processes11 and the inhibition of catabolic ones, such as
autophagy12,13. In response to growth factors, mTORC1 is mainly
activated through PI3K/AKT pathway-mediated inhibition of the
tuberous sclerosis complex 1/2 (TSC1/TSC2), thus allowing
interaction of the lysosomal GTP-loaded Rheb with the mTOR
catalytic domain and promoting its activation11. Amino-acid-
induced activation of mTORC1 is mainly transduced through the
Rag-GTPases, which mediate the translocation of mTORC1 from
the cytoplasm to the lysosomal surface14. Therefore, full activa-
tion of mTORC1 on the surface of the lysosome is only achieved
in the presence of both amino acids and growth factors12. Active
mTORC1 represses autophagy by acting on both ULK1 and
Vps34 complexes, therefore inhibiting autophagosome formation
and maturation, and suppresses lysosome biogenesis through
inhibition of TFEB. Conversely, different nutrient stress condi-
tions inactivate the mTORC1 pathway at different levels, thus
allowing triggering of autophagy, which enables cells to survive
upon unfavorable conditions by providing nutrients, which in
turn reactivate mTORC1 to terminate autophagy12,13,15.
Therefore, the highly intertwined mTORC1-mediated mod-
ulation of autophagy upon nutrient imbalance requires a complex
regulation to ensure cellular homeostasis. Although autophagy
has been classically perceived as a cell-autonomous process,
emerging evidence suggests that nutrients may also modulate
this process in a systemic manner via different types of cell sur-
face receptors. In particular, a variety of members of the G
protein-coupled receptors (GPCRs) family have been proposed as
nutrient sensors and suggested to be linked to the modulation of
autophagy16–18. In our search for new effectors and cellular
functions of the ubiquitous Gαq/11 subunits of heterotrimeric G
proteins, which are coupled to many GPCR19, we unveiled the
key participation of Gαq in the modulation of autophagy in
response to different types of nutrient stress and dissected the
downstream signaling events responsible for this regulatory effect.
Here, we demonstrate that Gαq/11 is central for the assembly of
active mTORC1 multimolecular complexes and consequently for
its inhibitory effect on autophagy.
Results
Gαq/11 is a potential modulator of autophagy. An altered
autophagic flux was noted when exploring potential differential
phenotypic features in wild-type (WT) versus Gαq/11 knockout
(KO) mouse embryonic fibroblasts (MEFs). Steady-state protein
levels of the autophagy markers LC3-II and p62 were higher and
lower, respectively, in Gαq/11 KO compared to WT MEFs in
nutrient-rich conditions (10% serum). These differences were
even more noticeable for LC3-II in low-serum conditions
(Fig. 1a). The addition of lysosomal proteolysis inhibitors
(NH4Cl/Leupeptin) for different times to analyze autophagic flux
revealed a markedly higher accumulation of LC3-II already at the
earlier time point, consistent with an accelerated induction of
autophagosome formation in Gαq/11 KO cells compared to
WT cells in both nutrient contexts (Fig. 1b). A higher number of
autophagic vacuoles (AV), mostly due to an increase in auto-
lysosomes (AUT) in Gαq/11 KO than in WT cells was also noted
in basal conditions using the tandem reporter mCherry-GFP-LC3
that allows tracking autophagic flux by the conversion of double
fluorescence-labeled vesicles (autophagosomes) into only red
fluorescence vesicles (autolysosomes) as GFP fluorescence is
quenched in the acid lysosomal lumen (Supplementary Fig. 1a).
Transmission electron microscopy (TEM) indicated an expansion
of autophagic vacuoles in Gαq/11 KO compared to WT MEFs
under nutrient sufficiency (Fig. 1c). Morphometry of TEM images
revealed a significant increase in the cellular area occupied by
autophagic vacuoles (Fig. 1d) at expenses of an increase in both
number and size of autolysosomes in the Gαq/11 KO MEFS
(Fig. 1e–f). In agreement with increased autophagic flux, we
observed a higher ratio of autolysosomes to autophagosomes
in cells lacking Gαq/11 (Fig. 1g and Supplementary Fig. 1a).
Furthermore, quantification of these autophagic structures by
flow cytometry also confirmed a significantly higher amount of
autophagic vacuoles under basal or low serum conditions in cells
lacking Gαq/11 (Supplementary Fig. 1b), which maintained intact
its viability under these nutrient conditions (Supplementary
Fig. 1c). Of note, stable re-expression of Gαq in the deficient
background (Gαq/11 KO+Gq MEFs) restored the basal pattern
of autophagy markers observed in WT MEFs (Fig. 1h), thus
ruling out an unspecific autophagic phenotype of Gαq/11 KO
MEFs unrelated to Gαq/11 dosage.
Gαq localizes in lysosomal and autophagic compartments. We
examined if Gαq/11 was localized in autophagic compartments in
physiological conditions, as described for different autophagy
modulators20. Since it is difficult to detect endogenous Gαq
protein with immunofluorescence techniques, we tested the pre-
sence of Gαq in autophagic/lysosomal compartments using sub-
cellular fractionation of liver tissue and immunoblot. We
uncovered the presence of Gαq in autophagosomes (APG) and
autolysosomes (AUT) and, with less abundance, in lysosomes
(Lys) isolated from fed rat livers (Fig. 1i). Upon a short period of
starvation (4 h), reported to lead to the upregulation of
macroautophagy21, Gαq distribution increased in Lys, thereafter
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regaining its predominant location in APG/AUT after a longer
starvation time (48 h) (Fig. 1i). Importantly, endogenous Gαq co-
localized in these structures with key autophagy-related signaling
components known to be located in such organelles as mTOR,
Raptor, and p62 (Supplementary Fig. 1d).
Many components of the autophagic machinery and autophagy
receptors (such as p62) present in these organelles are themselves
substrates of the process being subjected to lysosomal
degradation20. However, Gαq is not a substrate of autophagy
under nutrient stress conditions, since serum removal did not
promote a significant decrease of Gαq protein levels in WT MEFs,
or in cells deficient for Atg5, a well-established model of
macroautophagy deficiency, contrary to what was observed for
the known autophagy substrate p62 (Supplementary Fig. 2).
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Overall, the unexpected location of Gαq in autophagic compart-
ments and lysosomes and the fact that this protein is not
degraded under nutrient stress conditions in these organelles
suggested that the observed changes in autophagy upon Gαq
modulation may result from a regulatory function of this protein
on autophagy.
Cells lacking Gαq/11 display an earlier and prolonged autop-
hagic response upon different types of nutrient stress along
with an altered mTORC1 activation status. Consistent with the
accelerated autophagic flux observed in Gαq/11 KO versus WT
MEFs, analysis of the temporal pattern of autophagy markers in
these cells when subjected to low-serum conditions (Fig. 2a,
upper blots), absence of amino acids (Fig. 2b, upper blots) or
absence of glucose (Supplementary Fig. 3, upper blots), indicated
that Gαq/11 KO cells displayed an earlier and sustained autop-
hagic response in all nutrient stress contexts. p62 degradation and
LC3-II accumulation initiated at <4 h in Gαq/11 KO cells
(compared to 16 h in WT MEFs) following serum deprivation
(Fig. 2a, upper blots), or at 5 min (compared to >30 min in WT
MEFs) upon amino acids (Fig. 2b, upper blots) or glucose
removal (Supplementary Fig. 3, upper blots). Moreover, these
changes occurred in the same time frame that the increase in the
formation of autophagic vacuoles detected by flow cytometry in
Gαq/11 KO versus WT MEFs in all these experimental conditions
(Supplementary Fig. 4). These data suggested that Gαq/11 plays a
general and relevant role in the modulation of autophagy kinetics
in different situations of nutrient stress.
The main cellular nutrient sensor pathways converge in the
AMPK and mTORC1 cascades to regulate metabolism and
autophagy. Under nutrient-rich conditions (10% serum), in
agreement with their high basal autophagy, Gαq/11-deficient cells
displayed a significantly lower basal mTORC1 activation status
compared to WT cells in absence of changes in AMPK
stimulation (Supplementary Fig. 5a), associated with lower
proliferation rates (Supplementary Fig. 5b). Importantly, the
earlier autophagic response observed in Gαq/11-deficient cells in
the different nutrient stress contexts tested timely correlated with
an earlier, more marked, and prolonged inactivation of the
mTORC1 pathway compared to WT MEFs. The expected
attenuation of the mTORC1 cascade in WT cells upon low
serum (Fig. 2a), absence of amino acids (Fig. 2b), or glucose
(Supplementary Fig. 3) was clearly enhanced and noted before in
Gαq/11 KO MEFs, as assessed by the decreased phosphorylation
status of the S6 ribosomal protein (p-S6), a central mTORC1
cascade downstream target. A similar reduced stimulation pattern
was noted in Gαq/11-deficient cells for direct mTORC1 targets
such p70-S6K or the phosphorylation of ULK1 in Ser-757
(Supplementary Fig. 6a, b), whereas AMPK pathway modulation
was comparable in both cell types (Fig. 2a, b and Supplementary
Fig. 3, lower blots) in all conditions tested. Overall, these results
pointed out that Gαq/11 dosage might affect autophagy via the
modulation of the mTORC1 signaling hub in a variety of nutrient
stress contexts.
The specific activation of Gαq/11 leads to the activation of
mTORC1 and reverts the autophagic phenotype promoted by
nutrient stress conditions. We next sought to establish whether
the activation of Gαq/11 was linked to the modulation of the
mTORC1/autophagy pathways. Since canonical Gαq/11 stimula-
tion takes place upon agonist binding to GPCR, we used the
designer receptor exclusively activated by a designer drug
(DREADD) coupled to Gαq/11 (DREADD-Gq system) stably
expressed in HEK-293 cells. This model permitted to specifically
trigger Gαq/11 activation by the synthetic ligand Clozapine-N-
Oxide (CNO)22 without interference from endogenous signals
(scheme in Fig. 3a). As expected, CNO-mediated DREADD sti-
mulation promoted rapid and transient ERK1/2 and Akt
(Thr308) phosphorylation (positive controls of known Gαq
downstream cascades), as well as clear mTORC1 pathway acti-
vation noted at slightly longer times of treatment (Supplementary
Fig. 7a). Of note, in serum-starved cells (where downmodulation
of mTORC1 pathway and upregulation of autophagy takes place
(Fig. 3b, line 2) compared to conditions of 10% serum (Fig. 3b,
line 1)) prolonged stimulation with CNO fostered a sustained
activation of the mTORC1 cascade (as assessed by the p-S6
readout) eventually leading to inhibition of autophagy (decreased
LC3-II and increased p62 levels) to return to levels comparable to
the serum-supplemented conditions (Fig. 3b).
Fig. 1 Gαq/11 is a potential modulator of autophagy. a WT (n= 5) and Gαq/11 KO (n= 4) MEFs were cultured for 24 h with 10% or 0.1% FBS and
analyzed by immunoblot for LC3-I/II or p62 (WT n= 4, Gαq/11 KO n= 4) autophagic markers. Both markers were normalized with GAPDH. Data are
mean ± SEM of the indicated independent experiments. LC3-II/LC3-I graph: WT (10%) vs. Gαq/11 KO (10%), P value= 0.0091; WT (0.1%) vs. Gαq/11 KO
(0.1%), P value= 0.0389; WT (10%) vs. Gαq/11 KO (0.1%), P value= 0.0151. p62 graph: WT (10%) vs. WT (0.1%), P value= 0.0004; WT (10%) vs.
Gαq/11 KO (0.1%), P value= 0.0012. b WT and Gαq/11 KO MEFs starved with serum-free DMEM for 16 h were treated with a combination of NH4Cl (20
mM) and leupeptin (100 µM) (NH4Cl/Leu) during the last 4–6 h of the starvation period and autophagic markers assessed as above. A blot representative
of three independent experiments is shown. c Representative transmission electron microscopy images of WT and Gαq/11 KO MEFs maintained at 10%
FBS. Insets on the right show examples of autophagosomes and autolysosomes in WT and Gαq/11 KO MEFs. Scale bar, 0.5 µm. Black arrows indicate
autophagosomes and white arrows autolysosomes. Representative images of three independent experiments are shown. d–g Morphometric analysis of
micrographs as the ones shown in panel c to calculate the fraction of the cell occupied by autophagic vacuoles (AV) of WT (n= 11) or Gαq/11 KO (n= 10)
MEFs, P value= 0.0133 (d), number of autolysosomes (AUT) and autophagosomes (APG) of WT (n= 11) or Gαq/11 KO (n= 10) MEFs, P value (AUT)=
0.0011 and P value (APG)= 0.3040 (e), the average area of autolysosomes (AUT), WT(n= 22) and Gαq/11 KO (n= 32) MEFs, P value= 0.0146; and
autophagosomes (APG), WT (n= 19) and Gαq/11 KO (n= 8) MEFs, P value= 0.4615 (f), the fraction of total AV contributed by AT and APG, WT (n= 11)
or Gαq/11 KO (n= 10) MEFs, P values shown in the figure (g). Values are mean ± SEM of the indicated structures observed in >12 micrographs from three
independent experiments. h Comparative analysis of autophagic markers (representative blot and graph) and Gαq/11 (representative blot) in WT (n= 6)
or Gαq/11 KO (n= 5) MEFs and in cells re-expressing Gαq in the deficient background (Gαq/11 KO+Gq, n= 4) maintained in the presence of serum.
Data are mean ± SEM of four independent experiments, P value= 0.0429. i Immunoblot analysis of Gαq and of the lysosomal/autolysosomal markers
LAMP1 and Cathepsin D in autophagy-related organelles isolated from livers of fed or 4 and 48 h starved (ST) rats. Homogenate (Hom); cytosol (Cyt);
autophagosomes (APG); autolysosomes (AUT); lysosomes (Lys). A representative blot is shown. Densitometry quantification values are expressed as the
percentage of total Gαq protein associated to each autophagic/lysosomal compartment. Values are the mean ± SEM of four experiments. APG (Fed) vs.
LYS (Fed), P value= 0.0316; LYS (Fed) vs. LYS (4 h ST), P value= 0.0091; LYS (4 h ST) vs. LYS (48 h ST), P value= 0.0081; APG (48 h ST) vs. LYS (48 h
ST), P value= 0.0038. Statistical significance was analyzed using two-sided unpaired t-test. For all P values, *P < 0.05, **P < 0.005, ***P < 0.001. Source
data are provided as a Source Data file.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-24811-4
4 NATURE COMMUNICATIONS |         (2021) 12:4540 | https://doi.org/10.1038/s41467-021-24811-4 | www.nature.com/naturecommunications
Thus, we subjected DREADD-Gq cells to either low serum or
absence of amino acids nutrient stress conditions, and thereafter
Gαq/11 was specifically stimulated with CNO for different times
to check for potential mTORC1 reactivation and reversion of the
induced autophagic phenotype (see the scheme of experimental
approach in Fig. 3a). After 24 h in low-serum conditions (time 0
in the immunoblots shown in Fig. 3c), cells displayed the
characteristic features of autophagy induction (inactivation of the
mTORC1 pathway and increment of LC3-II levels compared to
the 10% FBS control situation) (Fig. 3c). In control cells (without
CNO stimulation), this pattern persists in the subsequent hours,
as assessed by the decreased status of p-S6 (Fig. 3c) and pS757-
ULK1 (Supplementary Fig. 7b) mTORC1 cascade readouts and
high LC3-II levels (Fig. 3c) and only slowly reverts at 16–24 h,
likely via the endogenous nutrients released by the autophagic
process. Strikingly, the specific activation of Gαq/11 by CNO led
to more marked and earlier (already observed at 1–4 h)
reactivation of the mTORC1 pathway (Fig. 3c, p-S6 readout,
pS757-ULK1 readout Supplementary Fig. 7b), also leading to an
earlier and stronger inhibition of autophagy, as detected by more
rapidly decreasing levels of LC3-II at 1–4 h of CNO treatment
compared to control non-Gq-stimulated cells (Fig. 3c). A similar
pattern of autophagy modulation was detected when testing the
evolution of p62 levels (Supplementary Fig. 7c). Once again, we
did not detect changes in the AMPK pathway. It is worth noting
that the reactivation of the mTORC1 pathway triggered by CNO
does not completely parallel the pattern of Akt activation (Fig. 3c
and Supplementary Fig. 7a), suggesting that other upstream
mTORC1 modulators would be involved in the effects of Gαq/11.
Consistent with this notion, a clear modulation of the mTORC1/
autophagy cascade upon activation of the CNO/Gαq-cascade was
observed in both 10 or 0.1% serum experimental conditions in the
absence of parallel changes in p-S473 Akt phosphorylation status
and also in the presence of Akti-1/2, a specific inhibitor of
canonical PI3K-dependent Akt stimulation that prevents its
phosphorylation by upstream kinases such as PDK1 (at T308)
Fig. 2 Cells lacking Gαq/11 display an earlier and prolonged autophagic response upon different types of nutrient stress along with an altered
mTORC1 activation status. a WT and Gαq/11 KO MEFs were maintained in presence or absence of serum during the indicated times (n= 4, except for
time 16 h, n= 3). WT (0.1%, 0 h) vs. Gαq/11 KO (0.1%, 0 h), P value= 0.0341. A representative blot of four independent experiments is shown. b WT and
Gαq/11 KO MEFs were maintained in the presence or absence of amino acids during the indicated times (n= 5). WT (EBSS, 120min) vs. Gαq/11 KO (EBSS,
120min), P value= 0.0407. A representative blot of five independent experiments is shown. For a and b, autophagic markers (LC3-II and p62) and the
activation levels of the mTORC1 and AMPK pathways were analyzed by assessing the phosphorylation status of the downstream target of mTORC1 S6
ribosomal protein (see Supplementary Fig. 6a, b for additional readouts of this cascade) or of AMPK, respectively. Tubulin and GAPDH (for the p-AMPK
and AMPK blots in panel a) were used as loading controls. Phospho-S6 data (mean ± SEM of the indicated independent experiments) were normalized
using total S6 ribosomal protein. Statistical significance was analyzed using two-sided unpaired t-test. For all P values, *P < 0.05. Source data are provided
as a Source Data file.
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and mTORC2 (at S473)23,24 (Fig. 3d and quantification in
Supplementary Fig 7d), whereas it was markedly attenuated by
the known mTOR kinase inhibitor rapamycin (Supplementary
Fig. 7e). These data were consistent with the occurrence of
alternative routes of Gq-mediated mTORC1 stimulation.
Similarly, stimulation with CNO for 30 min was also effective
in preventing mTORC1 pathway decrease in more acute settings
such as short-term exposure of cells to amino acid-free EBSS
media, as assessed by the status of p-S6 (Fig. 3e) or pS757-ULK1
and p-P70-S6K readouts (Supplementary Fig. 7f), or upon
exposure of cells to amino acid-free RPMI media supplemented
with dialyzed serum (Supplementary Fig. 7g), in the absence of
changes in the Akt of AMPK pathways (Fig. 3e). CNO-mediated
preservation of mTORC1 activation also attenuated the increase
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in LC3-II levels triggered by amino acid removal in control cells
(Fig. 3e, lower panels and Supplementary Fig. 7h).
Taken together, these results support that, in different contexts
of nutrient stress, specific activation of Gαq/11 triggers an earlier
and marked attenuation of the autophagic process (as if the cells
had partially recovered their nutrient levels) by promoting the
activation of the mTORC1 pathway. Consistent with this notion,
overexpression of constitutively active mutants of Gαq (Gq-
R183C and Gq-Q209L) was able to maintain mTORC1 pathway
activation even under low-serum conditions (Supplementary
Fig. 7i).
Gαq/11 is required to reactivate the mTORC1 pathway and
thus inactivate autophagy in response to nutrient recovery. We
next explored whether Gαq/11 was required for the reactivation
of the mTORC1 pathway that takes place once starved cells are
exposed to physiological nutrient levels. This mTORC1 reacti-
vation is essential to inactivate ongoing autophagy and return to
basal conditions. Two different refeeding paradigms were used. In
one set of experiments, WT and Gαq/11-deficient cells were
starved for 24 h in low-serum conditions and then treated with
increasing concentrations of serum for 18 h. Upon re-exposure to
serum, WT MEFs were competent to trigger the mTORC1 pathway
and to attenuate autophagy, while Gαq/11 KO MEFs were not able
to fully reactivate the mTORC1 cascade, particularly at lower serum
concentrations (Fig. 4a and Supplementary Fig. 8a, b). In another
approach, cells were starved in an amino acid-free medium for
30min followed by stimulation with a full amino acid mix for
5–60min. Similarly, amino acid recovery induced a rapid mTORC1
pathway stimulation and consequent attenuation of autophagy in
WT cells, but these nutrients were completely unable to promote
mTORC1 cascade activation (as indicated by the status of p-S6,
pS757-ULK1, or p-P70-S6K readouts) in Gαq/11 KO MEFs
that maintained autophagy abnormally upregulated (Fig. 4b and
Supplementary Fig. 8c, d).
As further evidence of Gαq/11-related changes in mTORC1-
modulated autophagy, we found changes in intracellular
positioning of endolysosomes in Gαq/11 KO cells compatible
with basal repression of mTORC1 signaling and upregulation of
autophagy. Immunofluorescence with LAMP1 to highlight the
endolysosomal compartment revealed that WT MEFs displayed
the expected switch of lysosomes from the cell periphery to a
more perinuclear location upon exposure to amino acid-free
medium25, whereas the re-exposure to amino acids restored their
original location (Fig. 4c). On the contrary, Gαq/11 KO cells
showed a predominant perinuclear lysosomal distribution even in
basal conditions, and such pattern was maintained in all the
experimental conditions (Fig. 4c and Supplementary Fig. 9).
These results are consistent with their inability to stimulate
mTORC1 in response to nutrient recovery. Of note, re-expression
of Gαq in the deficient background (Gαq/11 KO+Gq MEFs)
restored the pattern of lysosomal positioning observed in WT
MEFs. Consistent with the involvement of activated Gαq/11 in
mTORC1 modulation upon nutrient recovery, pretreatment of
WT MEFs with the specific Gαq/11 inhibitor YM-254890 before
amino acid supplementation markedly impaired its capacity to
reactivate the mTORC1 pathway, as indicated by the status of p-
S6, pS757-ULK1, or p-P70-S6K readouts (Fig. 4d). Overall, these
data strongly suggested that Gαq/11 is a relevant upstream
modulator of the highly intertwined mTORC1 complex. In order
to confirm this notion in a physiological model, we treated freshly
isolated liver explants from fed mice with YM-254890 or the well-
known mTORC1 inhibitor Rapamycin for 1 h (scheme in Fig. 4e).
The activated status of the mTORC1 pathway in fed conditions
was inhibited to a similar extent by Rapamycin or the Gαq/11
inhibitor (Fig. 4f), which was also able to dampen canonical Gαq/
11-mediated signaling pathways in such conditions (Supplemen-
tary Fig. 8e). Overall, our data indicated that Gαq/11 would help
to link different types of nutrient signals with mTORC1 in order
to modulate autophagy and coordinate metabolic responses to
nutrient fluctuations.
Gαq/11 is part of the mTOR/Raptor/p62 complex and favors
its assembly in the presence of nutrients. Intriguingly, immu-
noprecipitation of either endogenous Gαq (Fig. 5a) or mTOR
(Fig. 5b) from WT MEFs under nutrient-sufficiency conditions
revealed the presence of Gαq as part of the mTORC1 complex,
together with other key components such as Raptor and p62.
Importantly, immunoprecipitation of endogenous Raptor, a spe-
cific component of mTORC1, also revealed the presence in the
same complex of Gαq, p62, and mTOR (Fig. 5c). Notably, cells
lacking Gαq/11 displayed a lower association of p62 with mTOR
(Fig. 5b) or Raptor (Fig. 5c), suggesting that Gαq could favor
mTOR/p62/Raptor complex formation. The mTORC1 activation
complex formation undergoes a dynamic modulation upon
nutrient fluctuations15,26. Following amino acid deprivation, we
found dissociation of p62 from mTOR, while Raptor and Gαq
remained in the mTOR complex (Fig. 5d). In response to amino
acid replenishment, p62 re-associated to the mTORC1 complex.
These data suggested that Gαq/11 could favor the assembly of
components of the mTOR/p62/Raptor complex in the presence of
nutrients thus contributing to the activation of this pathway.
p62 associates with Gαq through a PB1-like interaction and
displays features of a Gαq effector. We searched for potential
molecular links between Gαq and mTORC1 activation. Interest-
ingly, we found that expression of a Gq-Q209L/R256A/T257A
Fig. 3 The specific activation of Gαq/11 leads to the activation of mTORC1 and reverts the autophagic phenotype promoted by nutrient stress
conditions. a Experiment outline diagram. DREADD-Gq-HEK-293 cells growing in 10% FBS were starved with 0.1% FBS medium (24 h) or EBSS (5 min)
and subsequently stimulated with vehicle or Clozapine-N-Oxide (CNO) (1 µM) for 1, 4, 16 or 24 h (serum context) or 30min (amino acid context). b Cells
growing in 10% FBS were starved for 16 h with serum-free medium and then stimulated or not with CNO (1 µM) for the indicated times. c Cells growing in
10% FBS were starved for 24 h with 0.1% FBS medium and stimulated with CNO or vehicle for different times. −CNO(1 h) vs. + CNO(1 h), P value=
0.0043; −CNO(4 h) vs. + CNO(4 h), P value= 0.0015; −CNO(16 h) vs. + CNO(16 h), P value= 0.0005. d Cells growing in 10% FBS or starved for 24 h
with 0.1% FBS medium were stimulated with CNO (1 µM) or vehicle for 4 h in the absence or presence of the AKTi-1/2 inhibitor (1 µM). e Cells growing in
10% FBS were starved for 5 min with EBSS and stimulated or not with CNO for 30min. ±CNO(0min) vs. –CNO(30min), P value <0.0001; ±CNO(0min)
vs. +CNO(30min), P value= 0.008. In the different panels, autophagic markers (LC3-I/II, p62) were analyzed by western blot and the activation of
mTORC1, Akt and AMPK pathways by assessing their phosphorylation status or that of downstream targets of mTORC1 (S6 ribosomal protein). Tubulin,
actin, or GAPDH were used as loading controls. Blots are representative of three (panels b, d, and panel e lower blots) or five (panels c and e) independent
experiments. Phospho-S6 data (mean ± SEM of five independent experiments) were normalized using total S6 ribosomal protein. See Supplementary
Fig. 7b–d for additional readouts and graphs related to these experiments. Statistical significance was analyzed using two-sided unpaired t-test. For all
P values, *P < 0.05, **P < 0.005, ***P < 0.001, ****P < 0.0001. Source data are provided as a Source Data file.
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(GqQL-AA) constitutively active GTPase mutant that disrupts
binding of Gαq to its canonical PLCβ and p63RhoGEF
effectors27,28, was able to promote activation of this pathway to a
significant extent under low-serum conditions (Fig. 6a), sug-
gesting that an additional effector binding through a different
region was involved in Gαq-dependent mTORC1 modulation.
A novel acidic region in Gαq responsible for its direct interaction
with the PB1-containing protein Protein kinase C ζ (PKCζ) has
been reported, and glutamic acid residues 234 and 245 proven to
be critical for such interaction29. Remarkably, the stimulation
of the mTORC1 pathway triggered by transient expression of
Gαq WT in low-serum conditions was not mimicked upon
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overexpression of the Gq-EEAA mutant (Fig. 6b). Overall, these
results suggested that the PB1-binding region of Gαq is involved
in mTORC1 pathway modulation.
Since the relevant autophagy receptor p62 contains both basic
and acidic PB1 domains30 and is present along with Gαq in the
same mTORC1 multimolecular complex under nutrient suffi-
ciency conditions (see above), we wondered whether the
modulation of mTORC1/autophagy pathways could involve a
PB1-mediated Gαq/p62 association. Interestingly, endogenous
Gαq/p62 co-immunoprecipitation was detected in MEFs (Fig. 5a)
and HUVEC (Supplementary Fig. 10a) cell types. We, therefore,
used transient overexpression of Gαq and HA-p62 constructs to
characterize their association. Of note, p62 displays features of a
bona fide Gαq effector (reviewed in ref. 19). Basal Gαq/p62
complex formation was fostered in a Gαq activation-dependent
manner, being transiently enhanced (peaking at 15–30 min)
upon Gαq activation by agonist-stimulated Gq-coupled M3
muscarinic receptors (Supplementary Fig. 10b), or in presence of
constitutively active Gαq mutants (Fig. 6c). Consistent with data
in Fig. 6a, b and with the notion that p62/Gαq association
mediates mTORC1 modulation via noncanonical cascades, the
GqQL-AA mutant, unable to interact with classical effectors as
PLCβ and p63RhoGEF27, was still able to efficiently bind p62
(Fig. 6d). Conversely, individual mutations to Alanine in
conserved residues of the PB1-binding region of Gαq, E234, or
E245 or a double E234/E245 mutation (Gαq-EEAA), markedly
decreased association with p62 compared to wild-type Gαq,
whereas the presence of the double mutant in a constitutively
active Gαq background (Gαq-R183C-E234/E245-AA mutant,
GαqRC-EEAA) was unable to potentiate the Gαq/p62 complex
formation observed with wild-type Gαq (Fig. 6e and Supple-
mentary Fig. 10c), confirming that E234 and E245 within the
PB1-binding region of Gαq were also essential for the interaction
of activated Gαq with p62.
In line with the features of a Gαq effector, Gαq/p62 association
was disrupted by a well-established negative modulator of Gαq
such as GRK2, but not by GRK2 mutants (GRK2-D110A)
defective in Gαq binding (Supplementary Fig. 10d). Of note,
Gαq mutants (Gαq-Y261F, Gαq-T257E, Gαq-W263D) unable to
bind GRK2 co-immunoprecipitated with p62 to an even greater
extent than wild-type Gαq (Supplementary Fig. 10e), and were
able to sustain mTORC1 pathway activation and modulate
autophagy to a higher extent than wild-type Gαq under 24 h in
low-serum conditions (Supplementary Fig. 10f), suggesting that
the absence of Gαq competitors favors the interaction with p62
and mTORC1 stimulation via the Gαq PB1-domain binding
region. Consistent with a PB1-like association between Gαq and
p62, the overexpression of the PB1 domain of p62 clearly inhibited
the complex formation (Fig. 6f). Of note, the PB1-mediated Gαq/
p62 association displays determinants somewhat different from
the Gαq/PKCζ interaction, since the Gαq-D236A mutant shows a
slightly increased interaction with p62 compared to WT while
decreased association with PKCζ (Supplementary Fig. 10c, g).
mTORC1 and autophagy modulation by Gαq correlates with
its ability to interact with p62. Importantly, we found that the
Gαq/p62 association was regulated by nutrient availability. A
progressive dissociation of the Gαq/p62 complex was detectable
at 16 h of serum starvation (Fig. 7a) and such decreased Gαq/p62
association was not due to potential autophagy-mediated p62
degradation in such long-term starvation conditions, since the
same effect was observed in the presence of lysosomal inhibitors.
Dissociation of the Gαq/p62 complex was also noted as earlier as
30 min of amino acids or glucose removal (Fig. 7b). Interestingly,
such patterns of Gαq/p62 complex dissociation correlated in time
with the deactivation of the mTORC1 pathway and the induction
of autophagy previously observed in these different contexts
of nutrient stress, suggesting a possible functional connection
between these processes.
To further establish whether the modulation of mTORC1 and
autophagy pathways by Gαq involved its interaction with p62, we
performed reconstitution experiments in Gαq/11 KO MEFs and
MEFs stably expressing, in a Gαq/11 KO background, similar
levels of either Gαq wt (Gαq/11 KO+Gq MEFs) or Gαq mutant
in its PB1-binding region with decreased Gαq/p62 interaction
(+Gq-EEAA), respectively (Supplementary Fig. 11a). Basal
activation status of the mTORC1 cascade and autophagy levels
correlated with the ability of Gαq mutants to interact with p62.
Fig. 4 Gαq/11 is required to reactivate the mTORC1 pathway and thus inactivate autophagy in response to nutrient recovery. a WT and Gαq/11 KO
MEFs were either maintained in the presence of 10% serum (control condition) or subjected to 24 h of starvation (0.1% FBS medium), followed by
stimulation for 18 h with increasing doses of serum. WT vs. Gαq/11 KO MEFs P value (0% FBS)= 0.0049; P value (0.1% FBS)= 0.0099; P value (1% FBS)
= 0.0330. b WT and Gαq/11 KO MEFs were either maintained in the presence of 10% serum or subjected to a 30min treatment with EBSS, followed by
stimulation with a full amino acid mix for the indicated times. WT vs. Gαq/11 KO MEFs P value (0min)= 0.0112; P value (15 min)= 0.0377; P value (30
min)= 0.0090; P value (60min)= 0.0177. Autophagy markers (LC3-I/II) were analyzed by western blot (see quantifications in Supplementary Fig. 8a and
c) and the activation of mTORC1 and AMPK pathways by assessing the phosphorylation status of downstream targets of mTORC1 (S6 ribosomal protein,
see Supplementary Fig. 8b and d for additional readouts of this cascade) or AMPK, respectively. Tubulin was used as a loading control. Phospho-S6 data
(mean ± SEM of three independent experiments) were normalized using total S6 ribosomal protein. Representative blots are shown. a, b Statistical
significance was analyzed using two-sided unpaired t-test. For all P values, *P < 0.05, **P < 0.01. c Altered intracellular positioning of lysosomes in Gαq/11
KO cells. Representative confocal micrographs of LAMP1 (red) and DAPI (blue) in WT, Gαq/11 KO and Gαq/11 KO+Gq MEFs in control conditions, after
30min in amino acid-free medium (EBSS) and upon re-exposure to amino acids for 15min (EBSS plus AA). Images are maximum intensity projections
acquired using Zeiss LSM780 confocal microscope using a ×63 Oil (NA= 1.4) oil immersion lends. Scale bar, 10 µm. Image on the right shows the
quantification analysis of lysosome distribution. The fluorescence intensity density per ring was measured and normalized as detailed in “Methods” and
Supplementary Fig. 9. Control (Wt, n= 30; Gαq/11 KO, n= 30 and Gαq/11 KO+Gq, n= 20); EBSS (Wt, n= 30; Gαq/11 KO, n= 30 and Gαq/11 KO+Gq,
n= 20); EBSS+ aa (Wt, n= 30; Gαq/11 KO, n= 28 and Gαq/11 KO+Gq, n= 22). Data are mean ± SEM from the indicated cells for each condition from
three independent different experiments. Statistical significance was analyzed using one-way ANOVA Sidak’s multiple comparisons test. For all P values,
****P < 0.0001. d–f The specific Gαq/11 inhibitor YM-254890 impairs reactivation of the mTORC1 pathway. d WT MEFs pretreated with YM-254890 (10
µM, 1 h) were maintained in the presence of 10% serum (control condition) or subjected to a 10min treatment with EBSS, followed by stimulation with a
full amino acid mix for 30min and analysis of mTORC1 cascade readouts. Representative blots of three independent experiments are shown. e Diagram for
mTORC1 pathway analysis in liver explants from fed mice subjected to YM-254890 (40 µM) or Rapamycin (500 nM) treatments for 1 h. The images used
in this diagram are from Servier Medical Art (http://smart.servier.com/). f Normalized p-S6 data (mean ± SEM of four mice) and a representative blot are
shown. Statistical significance was analyzed using two-sided unpaired t-test. For all P values, *P < 0.05. Control vs. YM-254890 (YM), P value= 0.0260;
Control vs. Rapamycin (Rapa), P value= 0.322. n.s. nonsignificant. Source data are provided as a Source Data file.
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Fig. 5 Gαq is part of the mTOR/p62/Raptor complex. Immunoprecipitation of endogenous Gαq (a), mTOR (b), or Raptor (c) was performed in WT (a) or
the indicated MEFs (b, c) under nutrient-sufficiency conditions (10% FBS). Blots are representative of three (a, c) and four (b) independent experiments. In
b (n= 4) and c (n= 3), data (mean ± SEM of the indicated independent experiments) were normalized by total mTOR (b) or Raptor (c) and expressed as
fold change of association with respect to the WT control condition. d Endogenous mTOR immunoprecipitation was performed as in panel b in WT MEFs
treated with EBSS for 30min and stimulated with a full amino acid mix for 15 min. Data (mean ± SEM of four independent experiments) were normalized by
total mTOR and expressed as fold-change p62 association with mTOR with respect to the 10% FBS control condition. Statistical significance was analyzed
using two-sided unpaired t-test. For all P values, **P < 0.01, ****P < 0.0001. b WT vs Gαq/11 KO (p62/mTOR association), P value= 0.0030. c WT vs.
Gαq/11 KO (p62/Raptor association), P value < 0.0001, and WT vs. Gαq/11 KO (mTOR/Raptor association), P value= 0.0047. d Control vs. EBSS, P value
= 0.0083. Source data are provided as a Source Data file.
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While Gαq/11 KO+Gq MEFs recovered the basal mTORC1
activation status of WT MEFs, cells displaying decreased Gαq/p62
interaction (+Gαq-EEAA MEFs) showed a pattern similar to
parental Gαq/11 KO MEFs with significantly lower mTORC1
pathway activation and, consistently, enhanced autophagy, as
indicated by higher LC3-II protein levels (Fig. 7c). Consistently,
analysis of endogenous mTOR complexes showed a decreased
association with Gαq and p62 in +Gαq-EEAA MEFs compared
to Gαq/11 KO+Gq MEFs (Fig. 7d). In serum or amino acid
starvation/recovery experiments, +Gαq-EEAA MEFs showed an
inefficient pattern of reactivation of the mTORC1 pathway and
maintained a high autophagy induction profile in response to
amino acids or serum recovery, similar to the patterns detected in
parental Gαq/11 KO MEFs (Fig. 7e and Supplementary Fig. 11b).
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Conversely, Gαq/11 KO+Gq MEFs efficiently recovered the
activation of mTORC1 and reversed the pattern of autophagy
markers (accumulation of p62 and decreased LC3-II levels) in
response to refeeding. Overall, these results support the notion
that the interaction between Gαq and p62 in response to nutrients
is key for the stimulation of the mTORC1 pathway and the
control of autophagy.
Discussion
We unveil here an unanticipated role of Gαq/11 as a key regulator
of macroautophagy via modulation of the mTORC1 signaling
hub. MEFs lacking Gαq/11 display higher basal autophagy and an
earlier and prolonged autophagy induction upon serum removal
or in the absence of amino acids or glucose than wild-type (WT)
cells. Gαq/11-deficient cells are also unable to inactivate ongoing
autophagy in response to nutrient replenishment. Our data sug-
gest that Gαq acts as a general and relevant modulator of
mTORC1 signaling over autophagy in response to fluctuations in
different types of nutrients.
The metabolic modulation of autophagy is mainly orchestrated
by the balance between the opposite inputs provided by the
mTORC1 (negative) and AMPK (positive) pathways12,31,32. Our
data provide insights into how Gαq/11 controls mTORC1 signaling
and autophagy in response to the availability of different types of
nutrients. First, cells lacking Gαq/11 display lower basal activation
of the mTORC1 cascade and an earlier and sustained inactivation of
this pathway compared to WT cells in response to all nutrient stress
conditions tested (low serum, absence of amino acids, or absence of
glucose), consistent with their enhanced autophagy response pat-
terns. Gαq/11 dosage does not affect the modulation of the AMPK
pathway under such nutrient stress conditions. Second, the specific
stimulation of Gαq/11 via a synthetic DREADD-Gq-coupled GPCR
promotes sustained activation of the mTORC1 pathway and trig-
gers an earlier reversion of the autophagic phenotype promoted by
serum or amino acids removal in parallel to the reactivation of the
mTORC1 cascade (and independently of AMPK status). Moreover,
constitutively active mutations in Gαq maintain mTORC1 activated
in absence of serum. Third, while WT MEFs subjected to a period
of starvation can fully reactivate the mTORC1 pathway and thus
inhibit autophagy upon a rescue treatment with serum or amino
acids, cells lacking Gαq/11 are unable to trigger such signaling
response, therefore maintaining autophagy activated. The intracel-
lular positioning of lysosomes in Gαq/11 KO cells is also compatible
with the repression of mTORC1 signaling and upregulation of
autophagy. Fourth, the Gαq/11 inhibitor YM-254890 prevents full
reactivation of the mTORC1 pathway upon amino acid recovery in
WT cells and inhibits the activated status of the mTORC1 pathway
in fed mice-derived ex vivo liver explants to an extent similar to that
attained in the presence of the well-known mTORC1 inhibitor
Rapamycin. Fifth, consistent with its role as an autophagy mod-
ulator, we demonstrate the presence of an endogenous Gαq pool
in autophagic compartments and lysosomes in rat liver, where it
co-localizes with mTOR, Raptor, and p62, and immunoprecipita-
tion of endogenous mTOR or Raptor from WT MEFs in the pre-
sence of nutrients shows that Gαq is part of the mTORC1
multimolecular complex.
We postulate that Gαq participates as a general modulator of
autophagy in response to serum, amino acids, or glucose by acting
as a relevant component of the mTORC1 complex scaffolding
machinery via interaction with the multifunctional p62/SQSTM1
protein. This signaling adaptor contains several functional regions
and displays a variety of subcellular locations, including autopha-
gosomes and lysosomes (reviewed in refs. 33,34). p62 plays a central
role as an autophagy receptor by forming PB1-linked homo-
oligomers, recruiting ubiquitinated cargos, and inducing nucleation
of the autophagosome membrane via its interaction with LC333
being itself a substrate of autophagy35. p62 is also involved in
other cellular processes33, including the modulation of mTORC1
(see below).
The mTORC1 signaling hub displays an intricate spatio-
temporal regulation, involving both upstream signaling path-
ways and timely recruitment to lysosomes12,13. Major
components of the mTORC1 complex include mTOR kinase,
mLST8, DEPTOR, and the specific regulatory protein Raptor,
which plays a relevant role in facilitating substrate recruitment
and in controlling mTORC1 subcellular localization12,13. Many
growth factors converge in promoting PI3K/Akt-mediated
phosphorylation of TSC2 and in its subsequent dissociation
from the lysosome, thus relieving its inhibition of the lysosomal
Rheb GTPase, which becomes able to interact with mTORC1
and activate it11,13. Importantly, the presence of amino acids,
acting through different sensors, is key for full mTORC1 acti-
vation by facilitating its recruitment to the lysosomal mem-
brane. This is achieved via the Ras-related GTP-binding protein
(Rag) family of small GTPases. An active Rag heterodimer
(GTP-loaded RagA/B and GDP-loaded RagC/D) tethered by the
Ragulator complex mediates the translocation of mTORC1 from
the cytoplasm to the surface of lysosomes (see references in
refs. 13,36–38). Glucose-dependent mTORC1 stimulation is also
partially regulated through Rag-GTPases by complex mechan-
isms (reviewed in refs. 31,39). Thus, Rags appear to integrate
multiple nutrient inputs converging in mTORC1 modulation.
Importantly, in the presence of amino acids, p62 has been
reported to interact with Raptor, thus helping mTORC1 com-
plex translocation to the lysosome40. In addition, p62 is required
for the interaction of mTORC1 with Rags, binds to RagC/D, and
favors the formation of the active RagB-GTP/RagC-GDP het-
erodimer, which is further stabilized by Raptor40. The presence
of p62 in the mTORC1 multimolecular complex might also
contribute to the full activation of kinase activity via TRAF6-
mediated K63 ubiquitination of mTOR41.
A number of evidence support a role for p62 as an effector
linking Gαq/11 to the activation status of mTORC1. First, p62,
mTOR, Raptor, and Gαq are present in the same multimolecular
Fig. 6 Gαq participates in the activation mechanism of mTORC1 via noncanonical effectors and associates with p62 through a PB1-like interaction.
a, b DREADD-Gq HEK-293 (a) or CHO cells (b) transiently overexpressing Gαq wt or the indicated Gαq mutants (constitutively active Gq-Q209L, active
but PLC-β activation-defective Gq-Q209L/R256A/T257A-GqQL-AA, mutant defective in binding to PB1-domain-containing proteins Gq-EEAA) were
starved or not with 0.1% FBS for 24 h. The dephosphorylation fold of S6 upon serum deprivation was calculated with respect to the 10% FBS control of
each cell population. A representative blot of three independent experiments is shown. c–f CHO cells were transiently transfected with the indicated
combinations of HA-p62, Gαq WT or the indicated Gαq mutants (constitutively active Gq-Q209L or GqRC, active but PLC-β activation-defective GqQL-
AA, defective in binding to PB1-domain-containing proteins Gq-EEAA and constitutively active GqRC-EEAA), or the PB1 domain of p62 (GFP-Flag-PB1-
p62). In all cases (c–f), co-immunoprecipitation assays and expression controls in lysates were performed as described under “Methods”. Representative
blots of three independent experiments are shown. e Data (mean ± SEM of three (Gq-EEAA and GqRC) or four (Gαq WT and GqRC-EEAA) independent
experiments) were normalized with total HA-p62 and expressed as fold induction of Gαq/p62 association over control. Statistical significance was
analyzed using two-sided unpaired t-test. Gαq WT vs. GqRC, P value= 0.0312. Source data are provided as a Source Data file.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-24811-4
12 NATURE COMMUNICATIONS |         (2021) 12:4540 | https://doi.org/10.1038/s41467-021-24811-4 | www.nature.com/naturecommunications
complex in endogenous conditions in the presence of nutrients,
whereas cells lacking Gαq display a reduced presence of p62 in
mTOR and Raptor immunoprecipitates along with decreased
mTORC1 pathway activation. Second, p62 displays most of the
features of a bona fide Gαq effector, including the association of
endogenous proteins, enhanced interaction upon Gαq activation
and competition of Gαq/p62 interaction by other well-known
Gαq interactors. Gαq and p62 appear to associate through a PB1-
like interaction, involving the PB1 domain of p62 and the acidic
PB1-binding region of Gαq, different from the specific interface
involved in the association of Gαq with the canonical PLCβ or
p63RhoGEF effectors19. This acidic Gαq region has been shown
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to interact with the PB1 domain of PKCζ29 or with the cold-
activated channel TRPM842, consistent with this Gαq region
being a functional module. Our data suggest that key Gαq acidic
residues such as E234/E245 would engage in specific electrostatic
interactions with canonical type II (positively charged) PB1
domains such as that present in p62. Importantly, the mTORC1
pathway activation status and the consequent reduction of
autophagy correlates with the ability of Gαq mutants to interact
with p62, as indicated by starvation/recovery experiments in Gαq/
11 KO MEFs and MEFs stably expressing, in a Gαq/11 KO
background, either WT Gαq (Gαq/11 KO+Gq MEFs), or a PB1-
binding region Gαq mutant with decreased (+Gq-EEAA) Gαq/
p62 interaction. Moreover, Gαq/p62 association is disrupted in
response to diverse types of nutrient stress (serum removal,
absence of amino acids or glucose) in parallel with mTORC1
cascade inactivation and consequent autophagy induction. On the
contrary, recovery of amino acids after starvation restores co-
immunoprecipitation of endogenous Gαq/p62/mTOR in WT
MEFs, suggesting that the re-association of Gαq and p62 in
response to nutrients facilitates the assembly of an active
mTORC1 multimolecular complex.
Given the reported interactions of p62 (via regions different
from its PB1 domain) with Raptor and Rags, leading to mTORC1
translocation to the lysosome and stabilization of active RagB-
GTP/RagC-GDP heterodimers40, it is tempting to hypothesize
that nutrient-dependent interactions of Gαq with the PB1 domain
of p62 may help to orchestrate a fully active mTORC/Raptor/p62/
Rag complex. Such core Gαq scaffolding role would be consistent
with its general role in autophagy control in response to different
types of nutrient stress (see scheme in Fig. 8). In nutrient-
sufficiency conditions, the presence of serum, amino acids, or
glucose would foster the PB1-like interaction between Gαq and
p62, leading to basal mTORC1 stimulation and preservation of
low, homeostatic autophagy levels. Upon starvation, Gαq/p62
dissociation would facilitate the PB1-domain-dependent partici-
pation of p62 in the autophagic pathway33. The release of internal
nutrients during autophagy (or the re-exposure to external fuels
or serum) would in turn facilitate Gαq/p62/mTORC1 complex
formation and reactivation in order to terminate autophagy.
However, the contribution of other Gq-triggered cascades to
Gαq-mediated modulation of mTORC1/autophagy pathways
cannot be ruled out. The canonical Gαq-governed PLCβ/IP3/
Calcium/PKC pathways appear to be involved in the stimulation
of mTORC1 by amino acids in pancreatic β cells43 and C2C12
myoblasts44, and calcium release from the endoplasmic reticulum
can inactivate autophagy by maintaining mTORC1 activity45.
Given the highly interconnected nature of the mTORC1 and Akt
pathways, including the existence of complex feedback
mechanisms46, potential intermodulation of canonical Akt cas-
cades and Gq/p62-mediated mTORC1 stimulation may also take
place. Therefore, such pathways might also contribute to the
overall effect observed, consistent with our findings showing that
the modulation of the mTORC1 cascade exerted by Gαq/11 is
only partially dependent on its canonical effectors.
Our results raise questions regarding the upstream signaling
molecules triggering Gαq/11 activation in response to nutrients
and the presence of Gαq/11 in lysosomal and autophagic orga-
nelles. An increasing number of nutrients and metabolites
are being identified as endogenous ligands for Gq-coupled
GPCR16,17,47. Intriguingly, a number of Gq-coupled GPCRs
widely expressed in many cell types have been reported to sense
amino acids and/or glucose, including the umami taste receptors
(T1R1/T1R3), the calcium-sensing receptor (CaSR), GPRC6A, or
metabotropic glutamate receptors43,48,49. T1R1/T1R3 receptors
negatively modulate autophagy in response to amino acids through
the activation of mTORC1 in a manner only partially dependent
on PLCβ50,51, whereas reduced T1R1/T1R3 expression in mice
lacking T1R3 impairs mTORC1 stimulation and enhances autop-
hagy in the absence of AMPK changes43, a phenotype similar to
that observed in Gαq/11 KO MEFs. On the other hand, relevant
serum components as lysophosphatidic acid or sphingosine-1-
phosphate and factors as insulin or IGF-1 have been reported to
directly stimulate Gαq signaling52.
The presence of Gαq in lysosomal and autophagy-related
organelles may be subsequent to receptor-mediated activation at
the plasma membrane or represent a stable pool able to undergo
nutrient-mediated stimulation at such locations. Recent data
indicate the presence of Gαq in endosomes and other organelles,
such as mitochondria49,53. The agonist-dependent presence of
GPCR and heterotrimeric G proteins in endosomes as a con-
sequence of GPCR recycling or degradation mechanisms has
also been reported49. Since endocytosis-derived organelles, can
Fig. 7 Gαq/p62 association is regulated by nutrient availability and mTORC1 and autophagy modulation by Gαq correlate with its ability to interact
with p62. a CHO cells were transfected with HA-p62 and Gαq constructs, starved with 0.1% FBS and treated with a combination of NH4Cl (20mM) and
leupeptin (100 µM) (NH4Cl/Leu) (N/L) during the last 4 h of the starvation period, or with EBSS or glucose-free media for the indicated times (b). An LC3-
I/II blot is shown to confirm the inhibition of autophagy by N/L. In both (a, b), co-immunoprecipitation assays and expression controls in lysates were
performed as described under “Methods”. Representative blots of three independent experiments are shown. c Basal activation status of the mTORC1
cascade and autophagy levels correlates with the ability of Gαq mutants to interact with p62. The basal activation status of the mTORC1 pathway in cells
growing under nutrient-sufficiency conditions (10% FBS) was checked by analyzing the phosphorylation status of the S6 ribosomal protein in wild type
MEFS, Gαq/11 KO MEFs and MEFs stably expressing in a Gαq/11 KO background either Gαq wt (+Gq MEFs) or a Gαq mutant (+Gq-EEAA) with decreased
Gαq/p62 interaction. S6 phosphorylation data from immunoblot analysis (mean ± SEM of 11 (WT), 9 (Gαq/11 KO and Gαq/11 KO+Gq), and 8 (Gαq/11
KO+Gq-EEAA) independent experiments) were normalized using total S6 ribosomal protein and expressed as fold change with respect to the WT MEFs
population. Basal autophagy levels were checked by analyzing LC3 protein levels by western blot and LC3-II/LC3-I ratios (mean ± SEM of four independent
experiments) expressed as fold change with respect to the WT MEFs population. Statistical significance was analyzed using two-sided unpaired t-test. For
all P values, *P < 0.05, ****P < 0.001. WT vs. Gαq11KO+Gq-EEAA, P value= 0.0402. d Endogenous mTOR immunoprecipitation was performed in Gαq/11
KO+Gq and Gαq/11 KO+Gq-EEAA expressing MEFs maintained under nutrient-sufficiency conditions (10% FBS). mTOR immunoprecipitates and total
lysates were analyzed by western blot with specific antibodies to determine the components of the complex and overall cell expression levels, respectively.
The blots shown are representative of three independent experiments. e mTORC1 reactivation and autophagy modulation in response to amino acid
recovery after starvation correlate with the ability of Gαq to interact with p62. As shown in the experimental outline diagram, all cell lines were treated or
not with EBBS for 30min and then stimulated with a full amino acid mix for 15 min. mTORC1/autophagy pathways modulation were analyzed by western
blot as in previous figures. S6 phosphorylation data (mean ± SEM of three (control and EBSS+ 15 aa) and four (EBSS) independent experiments) were
normalized using total S6 ribosomal protein and expressed as fold change over values in Gαq/11 KO MEFs population in each experimental condition.
Statistical significance was analyzed using two-way ANOVA with Bonferroni multiple comparison test. Gαq/11 KO (EBSS+ 15 aa) vs. Gαq/11KO+Gq
(EBSS+ 15 aa), P value= 0.0003. Source data are provided as a Source Data file.
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form elongation membranes to finally form autophagosomes in
response to starvation54, endosomes might constitute a source for
Gαq in autophagy-related organelles. Alternatively, activation of
Gαq by nutrient-sensitive GPCR could take place directly at
locations different from the plasma membrane via molecules that
can gain access to the intracellular milieu via specific transporters,
as is the case for amino acids, glucose, and other nutrients.
In sum, our results postulate Gαq as a key hub in the autop-
hagy machinery. The increasing links of altered autophagy with
relevant pathological conditions, such as metabolic disorders,
cancer, or cardiovascular diseases3–5, along with the central role
of Gαq/11 and Gq-coupled GPCR in the same contexts55,56,
suggest that the function or malfunction of this Gαq/mTORC1/
autophagy modulation cascade may contribute to these patholo-
gical situations and constitute a potential therapeutic target.
Methods
Experimental model and subject details
Rats. Adult male Wistar rats (200–250 g/8 weeks) fed or starved (4–48 h) were used
under an institutionally approved animal study protocol. All rats were housed
under pathogen-free conditions and handled according to protocols approved by
the Institutional Animal Care and Use Committee of Albert Einstein College of
Medicine (New York, USA).
Mice. Adult (8–12 weeks) male inducible endothelium-specific Gαq/Gα11-defi-
cient mice (Tie2-CreERT2; Gnaq f/f; Gna11− /− [EC-q/11-KO]57,58 fed with a
standard diet (SD, providing 13% of total calories from fat, 67% from
carbohydrate and 20% from protein; 2014S Rodent Maintenance Diet, Teklad,
Harlan, IN, USA) were used. Since for these experiments mice were not treated
with tamoxifen, we refer to them as WT mice as they display endogenous Gαq
levels. Mice were housed under a 12-h light–dark cycle with free access to food
and water and under specific pathogen-free conditions at 20–24 °C with a
humidity of 55% ± 10%. All animal experimentation procedures conformed to
the European Guidelines for the Care and Use of Laboratory Animals (Directive
86/609) and were approved by the Ethical Committees for Animal Experi-
mentation of our University and the Comunidad Autónoma de Madrid, Spain.
We did not use randomization in our animal studies. We were not blinded to the
group in our animal studies.
Cell lines. Gαq/11 WT and Gαq/11 KO MEFs were a kind gift from Dr. S.
Offermanns (Max-Planck-Institute for Heart and Lung Research, Germany). Atg5
WT and Atg5 KO MEFs were provided by Dr. N. Mizushima (University of Tokyo,
Tokyo, Japan) and DREADD-Gq-HEK-293 cells (human female) by Dr. Silvio
Gutkind (University of San Diego, California, USA)22. CHO cells overexpressing
the muscarinic M3 acetylcholine receptor (CHO-M3) (mice female) were a kind
gift from Dr. A. B. Tobin (University of Glasgow, UK). Cell lines were authenti-
cated by short tandem repeat (STR) or DNA barcoding analysis and tested for
mycoplasma contamination. MEFs and DREADD-Gq cells were maintained in
Dulbecco’s modified Eagle’s medium (DMEM) (Gibco Life Technologies), CHO-
M3 cells in αMEM (Gibco Life Technologies), supplemented with 10% (v/v) fetal
bovine serum (Sigma-Aldrich) and 1 mM L-glutamine, 50 IU/ml penicillin, 50 µg/
ml streptomycin. Human umbilical vein endothelial cells (HUVEC) (human male)
were grown in 199 Medium (Life Technologies, without NaHCO3) supplemented
with 2.2 g/L NaHCO3 (pH 7.4), 1 mM L-glutamine, 50 IU/ml penicillin, 50 µg/ml
streptomycin, and 15% FBS. After the first passage, cells were supplemented with
50 µg/ml endothelial cell growth supplements (Sigma-Aldrich) and 100 µg/ml
heparin (Sigma-Aldrich). All cell lines were maintained at 37 °C in a humidified 5%
CO2 atmosphere.
Fig. 8 Proposed scaffolding role of Gαq in the assembly of active mTORC1 complex to control autophagy in response to different types of nutrient
stress. Upper part: In nutrient-sufficiency conditions, the presence of serum, amino acids, or glucose would foster the PB1-like interaction between Gαq and
p62, leading to basal mTORC1 stimulation and preservation of homeostatic autophagy levels. Upon starvation, Gαq/p62 dissociation would facilitate the
PB1-domain-dependent participation of p62 in the autophagic pathway. The release of internal nutrients during autophagy would in turn facilitate Gαq/
p62/mTORC1 complex formation and reactivation in order to terminate autophagy. Lower part: Autophagy levels diagram. In response to starvation, there
is a controlled and transient upregulation of autophagy, with a subsequent return to basal levels upon the partial recovery of nutrients.
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Method details
Ex vivo liver explants. Freshly collected liver explants from fed male mice were
placed in dishes with DMEM in the presence or absence of the Gαq/11/14 inhibitor
(YM-254890, 40 µM), rapamycin (500 nM), or histamine (200 µM) and then
transferred to a 37 °C incubator at 5% CO2 for 1 h59. Explants were homogenized
using metal beads in a Tissue Lyser (Qiagen, Hilden, Germany)60, and lysates used
for immunoblot analysis of mTORC1 pathway modulation.
Cell treatments. For autophagy modulation by nutrient depletion assays, cells were
maintained in 0.1% (v/v) bovine serum, Earl’s balanced salt solution (EBSS) (1 g/L
D-glucose 2.2 g/L NaHCO3, 0.4 g/L KCl, 6.8 g/L NaCl, 0.6 g/L H2NaPO4 × 2H2O,
0.26 g/L CaCl2 × 2H2O, 0.2 g/L MgSO4 × 7H2O) or RPMI 1640 medium without
amino acids, sodium phosphate (US Biological R8999-04A) supplemented with
dialyzed serum during the indicated time periods. Nutrient recovery experiments
in MEF cells were carried out by adding increasing percentages of bovine serum or
a full amino acid mix (MEM amino acids solution (50×)) (Sigma-Aldrich). For
autophagic flux assays, cells were treated with chloroquine (50 µM, Sigma-Aldrich),
and a combination of the lysosomal proteolysis inhibitors ammonium chloride (20
mM, Sigma-Aldrich) and leupeptin (100 µM, Sigma-Aldrich), during the indicated
times. For degradation assays, cells were treated with the lysosomal inhibitors
mentioned and the proteasomal inhibitor MG132 (0.1 µM, Sigma-Aldrich) during
the indicated time. DREADD-Gq HEK-293 cells were stimulated with Clozapine-
N-Oxide (CNO) (1 µM, Tocris) during different times after being serum- or amino
acids-starved. Gαq/11 inhibition was carried out by cell treatment with the specific
Gαq/11/14 inhibitor (YM-254890, 10 µM, Wako) in serum-free media for 1 h.
CHO-M3 cells were stimulated with carbachol (10 µM, Sigma-Aldrich) in serum-
free media, during the indicated time periods. In order to analyze the implication of
mTORC1 or PI3K/AKT cascades in Gαq modulation of the mTORC1 pathway,
DREADD-Gq HEK-293 cells were treated with mTOR (Rapamycin, 500 nM,
Calbiochem) or AKT (AKTi-1/2, 1 µM, Tocris; Ref: 5773) inhibitors.
Plasmid DNA and transient transfections. pcDNA3 was from Invitrogen and Gαq-
Q209L cDNA from Missouri S&T cDNA Resource Center. The Gαq and Gαq-
R183C cDNA were from our laboratories (Dr. A. M. Aragay, CSIC, Barcelona,
Spain). The constitutively active Gαq mutant protein that lacks the ability to
interact with PLCβ (Gαq-Q209L/R256A/T257A) was provided by Dr. R. Lin (Stony
Brook University, New York, USA). The Gαq mutant proteins that lack the ability
to interact with GRK2 (Gαq-T257E, W263D, Y261F) were a gift from Dr. T.
Kozasa (The University of Tokyo, Japan). The PB1-binding region Gαq mutants
(Gαq E234A, D236A, D243A, E245A, E234/E245-AA, Gq-R183C-E234/E245-AA)
were generated in our laboratory using the QuickChange® site-directed muta-
genesis kit (Stratagene) following the manufacturer’s instructions29. GRK2, GRK2-
K220R, GRK2-D110A cDNAs were a gift from Dr. J. L. Benovic (The Kimmel
Cancer Center, USA). The GRK2-RH domain cDNA61 was generated in our
laboratory. The HA-p62 construct was provided by Dr. E. Campbell (University
of Illinois at Chicago, USA). GFP-Flag-PB1-p62 was provided by Dr. B. Berk
(University of Rochester, NY, USA). mCherry-GFP-LC3 (Addgene-84572, Dr. N.
Mizushima, constructed by T. Kaizuka (University of Tokyo, Japan)). cDNAs for
lentiviral construction pMD2.G, pSD.44 and psPAX2 (Addgene-12259, 12252,
12260, respectively) by Dr. R. Iggo (University of St Andrews, Edinburgh, UK). The
desired combinations of cDNA constructs were transfected using the Lipofecta-
mine 2000 method (Life Technologies), following the manufacturer’s instructions.
Cloning and mutagenesis. psd44.Gq-wt and psd44.Gq-E234-E245-AA were created
in our laboratory from psd44.GqQL (Addgene-46826, Dr. A. Mariotti) using the
QuickChange Lightning Site-Directed Mutagenesis Kit, following the manu-
facturer’s instructions (Agilent Technologies, 210,518). The constitutive activation
mutation was reverted with the following PCR primers: GqQ209L_FW: GAT GTA
GGG GGC CTA AGG TCA GAG AGA and GqQ209L_REV: TCT CTC TGA CCT
TAG GCC CCC TAC ATC. Subsequently, Gαq PB1-binding region mutations
were performed with the following primers: GqE234A_FW: CTAGTAGCGCTT
AGTGCATATGATCAAGTTCTCGTGG and GqE234A_REV: CCACGAGAA
CTTGATCATATGCACTAAGCGCTACTAG, GqD236A_FW: GTA GCG CTT
AGT GAA TAT GCG CAA GTT CTC GTG GAG TCA, GqD236A_REV: TGA
CTC CAC GAG AAC TTG CGC ATA TTC ACT AAG CGC TAC (Sigma-
Aldrich). All primers' information has been included in Supplementary Table 1.
Generation of stable cell lines. For the generation of MEFs stably expressing WT or
Gαq PB1-binding region mutants in a Gαq/11 KO background, firstly psd44.Gq-wt
and psd44.Gq-E234-E245-AA DNA constructs were transfected together with
psPAX2 and pMD2.G in HEK-293-T packing cells, using Metafectene (Bointex)
according to the manufacturer’s instructions, for the generation of the lentiviral
particles. Lentiviral purification and Gαq/11 KO MEFs transduction were
performed62. All generated MEF cells lines, psd.44.Gq-wt (Gαq/11 KO-rGq MEFs)
and pds44.Gq-EEAA (rGq-EEAA MEFs) MEFs were maintained under 1 µg/ml
puromycin treatment.
Generation of mCherry-GFP-LC3 MEFs stable cell lines. mCherry.GFP-LC3 stable
overexpressing cells were generated in Gαq/11 WT and Gαq/11 KO MEFs. Cells
were seeded in a six-well plate a day before transduction. Then, a 2× polybrene
mixture was prepared by adding 0.5 ml medium + 1μl polybrene stock solu-
tion (10 mg/ml) to the cells together with 0.5 ml mCherry-GFP-LC3 virus
supernatant generated by the same protocol as for psd.44 lentivirus vectors.
Next, 24 h after transduction, 1 ml of regular medium was added to the
cells without removing the virus supernatant. After 48–72 h, cells were
checked for positive GFP signal by fluorescence microscopy and seeded for
the experiment. Depending on the cell type these stable cell lines were used
until passage 3–4.
Immunoprecipitation assays. Cells were lysed with the low detergent lysis PD buffer
(50 mM Tris, pH 7.5, 150 mM NaCl, 1 mM NP-40, 0.25% (w/v) sodium deox-
ycholate, 1 mM EGTA pH 8.0, 1 mM NaF, protease inhibitors) 24–48 h after
transfection and clarified by centrifugation. Immunoprecipitation was performed
with agarose-conjugated anti-HA antibodies (Santa Cruz, F-7, # sc-7392-AC).
Endogenous immunoprecipitation assays were performed by incubating 0.5 µg/ml
of p62 antibody (GP62-G, Progen), mTOR antibody (7C10, Cell Signaling), Raptor
antibody (24C12, Cell Signaling), or Gαq antibody (E-17, Santa Cruz) or a control
IgG (normal rabbit IgG sc-2027, Santa Cruz) with 5 mg of cell lysates in the
presence of BSA (1 mg/ml), followed by re-incubation with Recombinant Protein
G-Sepharose™ 4B (Invitrogen, 101243).
SDS-PAGE and immunoblot analysis. The PD buffer supplemented with protease
inhibitors and 1 mM PMSF was used to make cell lysates. Protein concentration
was measured using the DC Protein Assay Reagents A, B, and S (Bio-Rad). Protein
lysates were separated on 8–15% SDS-PAGE gels, transferred onto the nitro-
cellulose membrane (Bio-Rad) and blocked for 1 h in 5% BSA–TBS. After incu-
bation with primary antibodies (overnight) and secondary antibodies (1 h), the
membranes were washed and analyzed using ECL (enhanced chemiLuminiscence)
from Amersham Pharmacia Biotech and AGFA films or the LI-COR Odyssey
Infra-red Imaging System. Immunoreactivity bands were quantified by laser den-
sitometry with a Biorad GS-900 scanner and using de Bio-Rad provided Image Lab
5.2 or by the software included in the Odyssey Infra-red Imaging System. Vertical
lines in western blots indicate juxtaposed lanes that come from the same gel but
were nonadjacent. Primary antibodies used in western blotting with dilutions were
as follows: AKT (Cell signaling #9272; 1:1000), p-AKT (S473) (Cell Signaling #4060;
1:1000), p-AKT (T308) (Cell Signaling #9275; 1:1000), AMPKα (Cell Signaling
#2532; 1:1000), p-AMPK (T172) (Cell signaling #2535; 1:1000), Tubulin (Santa
Cruz #SC-53030; 1:1000), Erk1 (C-16, Santa Cruz #SC-16; 1:1000), Erk2 (C-14,
Santa Cruz #SC-154; 1:1000), pERK1/2 (Thr202/204) (Cell Signaling #9101, 1:1000),
GAPDH (Abcam #ab8245; 1:5000), GFP (Santa Cruz #SC-9996; 1:1000), Gq/11
(C19, Santa Cruz #SC-392; 1:1000), Gq (E-17, Santa Cruz #SC-393; 1:1000), GRK2
(c-15, Santa Cruz #SC-562; 1:1000), HA (F-7, Santa Cruz #SC-7392; 1:1000),
LAMP1 (1D4B, Hybridoma Bank; 1:3000), LC3B (Cell Signaling #2775; 1:1000),
LC3B (NB100-2220, Novus Biologicals) mTOR (7C10, Cell signaling #2983;
1:1000), p62 (Progen, GP62; 1:1000), p62 (BML-PW9860, Enzo; 1:1000) p70-S6K
(Cell Signaling #2708; 1:1000), p-p70-S6K (Thr389) (Cell Signaling #9205; 1:1000),
Raptor (24C12) (Cell signaling, #2280; 1:1000), S6 ribosomal protein (Cell Signaling
#2217; 1:2000), p-S6 ribosomal protein (Ser240/244) (Cell Signaling #2215; 1:1000),
Ubiquitin (Sigma-Aldrich #U5379; 1:50), ULK1 (D8H5, Cell Signaling #8054;
1:1000), p-ULK1 (Ser-757) (Cell Signaling #6888; 1:1000). Secondary antibodies
coupled to HRP (Nordic Immunology): GAR/IgG(h+ L)/PO (16461, 1:50,000) and
GAM/IgG (H+ L)/PO (6513, 1:50,000) and secondary antibodies conjugated to
infra-red dyes (LI-COR): Guinea pig 800 nm (926-32411, 1:15,000), Rabbit 800 nm
(926-32211, 1:15,000) or 680 nm (926-68021, 1:15,000) and Mouse 800 nm (926-
32212, 1:15,000) or 680 nm (926-68022, 1:15,000).
Immunofluorescence. Cells previously seeded in glass coverslips, pre-coated with
polylysine 1× (Sigma), were fixed in 4% paraformaldehyde (15 min). Aldehyde
quenching was carried out by adding 10 mM glycine in PBS for 5 min and per-
meabilization with Triton X-100 at 0.5% in PBS twice (10 min), following by
blocking with 1% BSA for 1 h at RT. Cells were mounted with Fluoromount-G-
Dapi (Southern Biotech). Sample images were acquired using a confocal laser
microscope LSM710 (Zeiss) at ×63 magnification. Image J software (NIH) was used
for general image analysis and manipulations. Imaging of the mCherry-GPF-LC3
reporter was carried out using high-content microscopy. Cells were plated in a
glass-bottom 96-well plate and after incubation for the desired time, fixed with 4%
paraformaldehyde, and images were captured with a high-content microscope
(Operetta system, Perkin Elmer) Quantification was performed with the manu-
facturer’s software in a minimum of 2000 cells (~9 fields). The total number of
autophagic vacuoles (AV, autophagosomes plus autolysosomes) was estimated
from the number of mCherry-positive puncta, whereas puncta positive for GFP
and mCherry were scored as autophagosomes (APG). Autophagic flux was cal-
culated as the number of mCherry only fluorescent puncta (autolysosomes, AL)
per cell.
Quantification of lysosome distribution. Multi-channel fluorescence images for
DNA (Dapi), rat anti-Lamp1 (using Alexa 555, goat anti-rat IgG, ThermoFisher, as
a secondary antibody), and a cell tracer (Alexa 488, goat anti-mouse IgG1, Ther-
moFisher) were acquired in a Zeiss LSM780 confocal microscope equipped with a
×63 Oil (NA= 1.4) objective (MIP-IBMB). Cells were blindly selected using the
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green channel and, for each, a Z-stack was performed using 50 × 50 × 500 nm
voxel size.
Before quantification, the maximum intensity projection was obtained for each
cell image, and the cell and nucleus boundaries were extracted by respectively
manual and automatic segmentation. On the red channel, the background was
subtracted using the rolling ball algorithm (radius= 30 pixels), and the lysosome
distribution was then analyzed using an original ImageJ/Fiji script developed to
that purpose, available at https://github.com/MolecularImagingPlatformIBMB/
ringIntensityDistribution.63 Taking as reference the cell boundary, each cell was
divided in four concentric rings of equivalent area, being each ring isometrically
centered at the nucleus centroid. The fluorescence intensity density per ring was
then measured and normalized with respect to the total intensity density of the cell
(see Appendix Fig. S4 for details). At least 30 cells were measured for each
condition.
xCELLigence measurements. The xCELLigence system RTCA SP instrument
(Roche Applied Science) monitors changes in the cell index (a measure of cell
attachment to the plate) which has been shown to effectively correlate to pro-
liferation, adhesion, and viability changes64. To assess proliferation cells were
seeded in a 96-well gold electrode sensor plate (E-plates 16) and monitored every
15 min for varying times (50–100 h) in 10% FBS. Cell index (CI) values were
normalized 7 h after plating (to exclude the adhesion phase). Cell growth was
calculated as the slope (hours-1) of the cell index curve during a total of 50 h. In no
case was cell death due to excessive confluence as confirmed by plate inspection
with a microscope.
Annexin V/7-AAD binding. To quantitatively measure apoptosis, the PE Annexin V
Apoptosis Detection kit I (BD-Bioscience) was utilized. Gαq/11 WT and Gαq/11
KO MEFs at 90% confluency were starved during 24 h with 0.1% FBS after which
cells were re-suspended in Annexin V-binding buffer (0.1 M HEPES/NaOH (pH
7.4), 1.4 M NaCl, 25 mM CaCl2). Samples were analyzed by flow cytometry on a
BD FacsCalibur flow cytometer (BD-Bioscience). To determine the apoptotic stage
of the different cell populations, 7-AAD- and Annexin V-positive cells were
determined with the CellQuest Pro Version 4.0 Software (BD-Bioscience) and
analyzed with the FlowJo Software (v7.6.5 and v10.0.8r1). Cells treated with
staurosporine (2.5 μM, 2 h) or ultraviolet irradiation (2 h) were considered the
apoptotic (annexin V-positive) and necrotic (7-AAD-positive) controls,
respectively.
Autophagy detection in living cells by flow cytometry. The autophagic activity of
serum, amino acids, or glucose-starved WT and Gαq/11 KO MEF cells was
monitored using Cyto-ID Autophagy Detection Kit (Enzo Life Sciences)
according to the manufacturer’s instructions. Treatment with chloroquine
(50 µM, Sigma-Aldrich) during the last 4 h of the serum starvation treatment or
during 4 h before the amino acids or glucose removal, allowed quantifying the
autophagic flux. Samples were analyzed by flow cytometry on a BD FacsCalibur
flow cytometer (BD-Bioscience), and data were analyzed with the FlowJo
software.
Transmission electron microscopy and morphometric analysis. For conventional
TEM, Gαq/11 WT and Gαq/11 KO MEFs grown at 10% FBS were fixed in situ for
2 h at room temperature with a mixture of 4% PFA and 2% glutaraldehyde in 0.1 M
Sörensen phosphate buffer (pH 7.4). After several washes, cells were scraped and
collected in the same buffer, centrifuged and the cell pellets were processed for
embedding in the Epoxy, TAAB-812 resin (TAAB Laboratories) according to
standard procedures65. Ultrathin sections (70–80 nm) of the cell samples were
stained with 2% uranyl acetate solution in water and lead Reynolds citrate and
examined at 80 kV in a Jeol JEM-1010 (Tokyo, Japan) electron microscope. Pic-
tures were taken with a TemCam-F416 (4 K × 4 K) digital camera (TVIPS).
Autophagic vacuoles were identified using established criteria59. Autophagic
vacuoles (vesicles of 0.5 µm) were classified as autophagosomes when they met two
or more of the following criteria: double membranes (complete or at least partially
visible), absence of ribosomes attached to the cytosolic side of the membrane,
luminal density similar to the cytosol, and identifiable organelles or regions of
organelles in their lumen. Vesicles of similar size but with a single membrane
(or <40% of the membrane visible as double), luminal density lower than the
surrounding cytosol, or multiple single membrane-limited vesicles containing light
or dense amorphous material were classified as autophagolysosomes. Total
autophagy vacuoles were composed of the sum of autophagosomes and auto-
lysosomes. The maturation of autophagy vacuoles was calculated as the percent of
autolysosomes and autophagosomes out of the total number of autophagy vacuoles.
Isolation of subcellular fractions. Autophagic vacuoles were isolated from rat liver
using discontinuous metrizamide density gradient66. Briefly, after homogenization,
livers were subjected to sequential differential centrifugations to separate a fraction
enriched in autophagy-related compartments and mitochondrial. This fraction was
placed at the bottom of a discontinuous (three layers) gradient of metrizamide and
upon centrifugation, mitochondria remained at the bottom whereas a fraction
enriched in autophagosomes is recovered in the top band and in autolysosomes in
the second band from the top. A lysosomal enriched fraction is also recovered from
the third band of the gradient from the top. Upon extensive washing with 0.25M
sucrose, fractions are systematically analyzed for protein markers and lysosomal
enzymatic activity67. Cytosolic fractions were obtained by centrifugation for 1 h at
100,000×g of the supernatant obtained after separating the
mitochondria–lysosome– enriched fraction.
Quantification and statistical analysis
Quantification. Immunoreactivity bands were quantified by laser densitometry
with a Biorad GS-900 scanner and using de Bio-Rad provided Image Lab 5.2
(https://www.bio-rad.com) or by the software Application Software Version 3.0 LI-
COR (Biosciences), included in the Odyssey Infra-red Imaging System.
Flow cytometry data were analyzed with the FlowJo Software V7.6.5 and
V10.0.8r1 (https://www.flowjo.com).
Image J software v1.53j (NIH) was used for general image analysis and
manipulations (https://imagej.nih.gov/ij/index.html).
Excel (v1905) was used for data analysis quantification.
Statistics. All data are presented as mean values ± SEM of the indicated number of
independent experiments stated in the figure legend. We determined the statistical
significance in instances of single comparisons by two-sided unpaired Student’s t-
test and in instances of multiple means comparisons by one-way ANOVA followed
by the Bonferroni’s test as specified in each figure legend. All statistics were
obtained using GraphPad Prism 8 software (https://www.graphpad.com/). The
differences were considered significant when *P < 0.05, **P < 0.01, ***P < 0.001,
and ****P < 0.0001.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
List of Figures that have associated raw data are Figs. 1–7 and Supplementary Figs. 1–11.
Other data that support the findings of this study are available from the corresponding
authors upon reasonable request. No datasets were generated or analyzed during this
study. All unique materials generated are readily available from the authors. Source data
are provided with this paper.
Code availability
An original Fiji macro has been developed and deposited in a Github repository
(https://doi.org/10.5281/zenodo.4815136).
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